Dr. Yanis Rabah Amrani, MD

Dr. Amrani practices at University of Mississippi Medical Center in Jackson, Mississippi, part of Mississippi Institutions of Higher Learning.

Dr. Amrani's NPI, 1144882473, was assigned on July 8, 2019. Dr. Amrani holds Mississippi license 31548.

Dr. Amrani's primary practice is University of Mississippi Medical Center, at 2500 N State St, Jackson, MS 39216 in Hinds County. The practice phone is (601) 984-4100.

Dr. Amrani's primary practice is University of Mississippi Medical Center in Jackson, Mississippi, part of Mississippi Institutions of Higher Learning. The medical group on file is University of Mississippi Medical Center. Dmand AI also links Dr. Amrani to 1 more behavioral health center, named with a free account. Dr. Amrani's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amrani practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Amrani's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Amrani's licenses on file in 2 states: Mississippi and Texas.

CMS data shows 234 Medicare services from Dr. Amrani across 5 procedure codes in 2024, for 181 Medicare patients. Medicare paid $21,724 for them.

CMS counts 181 Medicare patients who saw Dr. Amrani in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Amrani's median patient age at 50, with 65% women.

In 2024, Dr. Amrani wrote 606 Medicare Part D claims for 111 patients. 90% of them were for generic drugs. CMS names the drug for 417 of them, across 17 drugs with 11 or more claims each, at $72,638 in total drug cost. In 2023, CMS named 19 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Amrani for performance year 2024, reported as part of a group. Dr. Amrani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Amrani as offering telehealth.

CMS Open Payments shows 31 general payments to Dr. Amrani from 15 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $141.